Replies to post #397098 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Yes george h this is how I remember it. The first phase2 ABSSSI trial was at a much higher dosage which caused hypertension issues. Polymedix planned a second trial at a much lower dosage but never had a chance to implement the changes, when CTIX now IPIX picked up Brilacidin Leo and company ran the second trial using Polimedix dosage changes.